About the Event: Thomas Conlon, Chief Scientific Officer of Michelson Philanthropies, will speak on a panel about the future of the mRNA revolution during the Milken Institute’s Future of Health Summit. Messenger RNA, or mRNA, has been a focus of research for...
Maintaining mRNA’s momentum will require continued investment, effective collaboration, and philanthropic contributions, Dr. Thomas Conlon of Michelson Philanthropies said on a panel at the Milken Institute’s Future of Health Summit. Hundreds of medical...
The USC Michelson Center for Convergent Bioscience is celebrating the fifth anniversary of its opening in 2017. Dr. Gary K. Michelson recently visited the center to learn about the latest research being conducted with state-of-the-art equipment. The USC...
Michelson Philanthropies’ Chief Scientific Officer Thomas Conlon joins the 2022 Milken Institute Future of Health Summit alongside a panel of vaccine development and biomedical experts to discuss the potential and advancements of mRNA. Messenger RNA, or mRNA,...
Michelson Philanthropies attended the Science Writers conference in Memphis, Tennessee, and honored two journalists for winning a prestigious medical science reporting award. By Justin Chapman Michelson Philanthropies celebrated science journalism in Memphis,...